Landauer Inc (NYSE:LDR) shares saw unusually-high trading volume on Thursday . Approximately 248,802 shares changed hands during trading, an increase of 382% from the previous session’s volume of 51,664 shares.The stock last traded at $67.73 and had previously closed at $67.70.

LDR has been the subject of a number of research analyst reports. Zacks Investment Research lowered shares of Landauer from a “buy” rating to a “hold” rating in a research report on Wednesday, May 10th. BidaskClub raised shares of Landauer from a “sell” rating to a “hold” rating in a research report on Tuesday, August 15th. Finally, Hilliard Lyons raised shares of Landauer from an “underperform” rating to a “neutral” rating in a research report on Wednesday.

The firm has a market capitalization of $655.38 million, a PE ratio of 35.21 and a beta of 1.27. The stock has a 50-day moving average of $58.95 and a 200-day moving average of $53.37.

Landauer (NYSE:LDR) last announced its quarterly earnings results on Tuesday, August 8th. The scientific and technical instruments company reported $0.67 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.49 by $0.18. The company had revenue of $39.89 million for the quarter. Landauer had a net margin of 16.55% and a return on equity of 96.20%. On average, equities research analysts expect that Landauer Inc will post $1.92 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 3rd. Investors of record on Friday, September 15th will be paid a $0.275 dividend. This represents a $1.10 dividend on an annualized basis and a yield of 1.62%. The ex-dividend date is Thursday, September 14th. Landauer’s payout ratio is 56.99%.

A number of institutional investors have recently made changes to their positions in LDR. Great West Life Assurance Co. Can boosted its stake in Landauer by 8.3% in the 1st quarter. Great West Life Assurance Co. Can now owns 13,533 shares of the scientific and technical instruments company’s stock worth $659,000 after purchasing an additional 1,033 shares in the last quarter. Eqis Capital Management Inc. bought a new position in Landauer in the 1st quarter worth about $266,000. Bank of New York Mellon Corp boosted its stake in Landauer by 3.0% in the 1st quarter. Bank of New York Mellon Corp now owns 167,586 shares of the scientific and technical instruments company’s stock worth $8,170,000 after purchasing an additional 4,910 shares in the last quarter. Comerica Bank boosted its stake in Landauer by 3.9% in the 1st quarter. Comerica Bank now owns 10,623 shares of the scientific and technical instruments company’s stock worth $568,000 after purchasing an additional 398 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in Landauer by 4.9% in the 1st quarter. Ameriprise Financial Inc. now owns 50,226 shares of the scientific and technical instruments company’s stock worth $2,448,000 after purchasing an additional 2,325 shares in the last quarter. Institutional investors own 80.99% of the company’s stock.

WARNING: “Landauer Inc (LDR) Sees Unusually-High Trading Volume” was first posted by Daily Political and is the sole property of of Daily Political. If you are reading this news story on another website, it was illegally stolen and reposted in violation of US and international copyright laws. The legal version of this news story can be accessed at https://www.dailypolitical.com/2017/09/07/landauer-inc-ldr-sees-unusually-high-trading-volume.html.

About Landauer

Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.